| Useful Advices |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Top7 or 10 Tips > Seven Steps to Motivating People at Work |
|
Useful Advices - Seven Steps to Motivating People at Work
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ssionate about" and taking what they say at face value. Look for body language signs that reinforce their stated passion. In an era of self help by means of television, radio and new age music, almost everyone is convinced they need to be passionate about something and quite often make it up, even to themselves. It is bet ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in er to have a conversation, asking how things could be done better around here. Respond with further questions to explore. The phrase, "Tell me more" works well to open up the conversation further. Have several conversations like this and as trust develops you will find out what motivates people without having to ask. Havi lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. g a conversation with people where you are genuinely interested in their responses builds self esteem for the person to whom the questions are directed. For major and minor changes, go further than asking for advice and opinions; involve people in analysis and design of solutions. It is not necessary to set u here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe quality circles as part of a complete quality management system. Involve people in the definition of the problem and they will own it. Involve them in the analysis to create solutions and they will own the solution alternatives. Involve them in the design of the implementation and they will own the outcome. d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro e When you are anticipating change, let people know what your intentions are. Tell them the goal. Tell them the rationale. Tell them the consequences and timing of what you intend to do. Tell them the consequences and timing of doing nothing. Tell them the process by which things will happen. Tell them how to find out mor ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc e information. Tell them how to make sure their comments and thoughts are to be included. Listen to what they think. Listen to what they would rather do. Listen to their aspirations. Listen to how changing things impacts them. Do this for good news and bad news. Do this as early as possible, often and by several differen easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi mediums. Do this for big events and do it on a small scale for small events, such as responding to a conversation you started by asking, "How can we do things better around here." In day-to-day business life communicate the standards to which you expect people to perform. Make them explicit standards, not implicit. Do no nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ask for a public toilet to be clean. Develop a standard on what clean is. The standard will include as a minimum, what is to be done, the measure by which it is evaluated and time elements. People are not de-motivated by certainty. They are, however, de-motivated by the uncertainty created by the whirlpool of rumour and and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ enial resulting from a vacuum of information when change is anticipated. They are de-motivated by the duplicity of informal standards when none is formally set. Appreciate people's achievements in public. Even those who shun the limelight will appreciate being commended in a low key way in public. Be speci ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ic. Do not say, "I just want to commend Jim for the great job he is doing". The assembled group, including Jim, is likely to have two or more views on what behaviours "Doing a great job" reflects. Say instead, "I want to commend Jim for going out of his way to help our customer stay in business. Jim not only came in on Sa ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a turday morning when the customer called in a panic, but he personally delivered the part. Jim did not have to do that. In choosing to do so, he has helped us all get a reputation for superior service". Nobody is left in doubt as to what behaviour, with what consequences, is being commended. It is this precise behaviour whi dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod h will be reinforced. Reprimand in private. People will talk and the fact a reprimand has been given will be known. Embarrassing people in public will de-motivate. Reprimanding in a constructive manner will motivate. Reprimand as soon as possible after the event and be as specific about the behaviour which cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin is unacceptable and the rationale as to why it is unacceptable as for appreciating behaviour. Be specific about the consequences of repeating the behaviour. Ask for advice on what can be done to help the person stop the behaviour. Work together to eliminate the unacceptable behaviour. If the reprimand does not work, couns tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen l to improve or find employment where the behaviour is acceptable. Do not shirk your responsibility to all the other people exhibiting acceptable behaviours, so that a distinction between acceptable and unacceptable behaviour is made. Build people's strengths and help them eliminate their weaknesses. Make it un t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel cceptable to continue in a position where a weakness is a liability for the team. However, make it acceptable to have a weakness on which people are willing to work. Help them help themselves. Allow more skilled team members to help them. Monitor progress and appreciate progress. Identify, appreciate and build people's st ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust rengths, especially those who have weaknesses they are working on. Use all resources at your disposal you can afford. Not only use coaching and training but ask people to train and coach others. Nothing makes people realise their true strengths and weaknesses more than when they are asked to teach. Nothing builds self est y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products em like being successful at teaching someone else well and watching their behaviour change. Delegate your responsibilities to people who have the competence to execute some of your tasks. State clearly what is expected, setting a standard which is mutually understood. Delegate the authority. Do not double ch . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ck them as routine. At the beginning of delegation monitor their output as part of an greed standard of handing over delegation. At an agreed level of execution quality, stop monitoring except for normal quality audit purposes. Make sure the data required to execute the tasks is easily accessible. At work, being elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip responsible, having the competency, authority and tools to be responsible and having the trust of your colleagues, superiors and subordinates is the most powerful motivator of all. Find something, even the smallest thing that an individual can actually be responsible for and you will be on the road to a motivated workforce tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Organizational Change: How to Foster and Manage Change Are You As Dumb As I Was About Sales?
|